Nutrien Stock Forecast, Price & News

Nutrien's stock was trading at $32.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NTR stock has increased by 27.1% and is now trading at $40.68.
View which stocks have been most impacted by COVID-19.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 7 hold ratings, 12 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Nutrien.

Nutrien is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Nutrien.

Nutrien will be holding an earnings conference call on Monday, November 2nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Nutrien Ltd (NYSE:NTR) released its quarterly earnings results on Monday, August, 10th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.37 by $0.08. The firm had revenue of $8.42 billion for the quarter, compared to analyst estimates of $8.32 billion. Nutrien had a return on equity of 4.26% and a net margin of 4.08%. The business's quarterly revenue was down 3.2% on a year-over-year basis. During the same quarter last year, the business earned $1.58 EPS.
View Nutrien's earnings history.

Nutrien announced a quarterly dividend on Monday, August 10th. Investors of record on Wednesday, September 30th will be paid a dividend of $0.45 per share on Friday, October 16th. This represents a $1.80 annualized dividend and a yield of 4.42%. The ex-dividend date of this dividend is Tuesday, September 29th.
View Nutrien's dividend history.

Nutrien issued an update on its FY20 earnings guidance on Monday, August, 10th. The company provided earnings per share guidance of $1.50-1.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.62.

20 brokers have issued 1 year price targets for Nutrien's stock. Their forecasts range from $39.00 to $55.00. On average, they anticipate Nutrien's stock price to reach $46.29 in the next twelve months. This suggests a possible upside of 13.8% from the stock's current price.
View analysts' price targets for Nutrien.

Nutrien saw a decline in short interest in the month of October. As of October 15th, there was short interest totaling 4,070,000 shares, a decline of 26.1% from the September 30th total of 5,510,000 shares. Based on an average trading volume of 1,520,000 shares, the days-to-cover ratio is presently 2.7 days. Currently, 0.7% of the shares of the company are short sold.
View Nutrien's Short Interest.

Some companies that are related to Nutrien include The Scotts Miracle-Gro (SMG), The Mosaic (MOS), CF Industries (CF), ICL Group (ICL), American Vanguard (AVD), Bioceres Crop Solutions (BIOX), Bioceres Crop Solutions (BIOX), Marrone Bio Innovations (MBII), Calyxt (CLXT), CVR Partners (UAN), Evogene (EVGN), Wynnstay Group Plc (WYN.L) (WYN), Eden Research (EDEN), China Green Agriculture (CGA) and Bion Environmental Technologies (BNET).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Toronto Dominion Bank (0.79%), Galibier Capital Management Ltd. (0.21%), QV Investors Inc. (0.14%), Artemis Investment Management LLP (0.10%), PM CAPITAL Ltd (0.07%) and Alberta Investment Management Corp (0.07%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Addenda Capital Inc., Hexavest Inc., Envestnet Asset Management Inc., Alberta Investment Management Corp, QV Investors Inc., Livingston Group Asset Management CO operating as Southport Capital Management, Shufro Rose & Co. LLC, and Lesa Sroufe & Co.

NTR stock was acquired by a variety of institutional investors in the last quarter, including Toronto Dominion Bank, Artemis Investment Management LLP, Galibier Capital Management Ltd., PM CAPITAL Ltd, Harvey Capital Management Inc., AMG National Trust Bank, DekaBank Deutsche Girozentrale, and Meritage Portfolio Management.

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $40.68.

Nutrien has a market capitalization of $23.15 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

The official website for Nutrien is www.nutrien.com.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]